Anne Sexton
Dermatology · Fort Mill, SCNPI 1578954145
Payments from drug & device makers
Across 593 payments — averaging $22.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Sanofi$1K
- Regeneron Healthcare Solutions, Inc.$1K
- Sun Pharmaceutical Industries Inc.$1K
- Johnson & Johnson$920
- Arcutis Biotherapeutics, Inc.$897
- plus $6K from 25 others
What the payments were for
- Speaking & faculty fees$280%
- Food & beverage$13,15197%
- Education$3733%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 112 | $2,591 |
| Sanofi | 46 | $1,197 |
| Regeneron Healthcare Solutions, Inc. | 61 | $1,151 |
| Sun Pharmaceutical Industries Inc. | 44 | $1,140 |
| Johnson & Johnson | 56 | $920 |
| Arcutis Biotherapeutics, Inc. | 35 | $897 |
| E.r. Squibb & Sons, L.L.C. | 31 | $851 |
| Novartis | 26 | $596 |
| UCB, Inc. | 18 | $582 |
| Lilly USA, LLC | 17 | $553 |
| Pfizer | 25 | $459 |
| Dermavant Sciences, Inc. | 15 | $427 |
| Amgen | 16 | $387 |
| Incyte Corporation | 15 | $255 |
| Mayne Pharma Commercial LLC | 10 | $241 |
| Galderma Laboratories, L.p. | 17 | $240 |
| Verrica Pharmaceuticals Inc. | 9 | $178 |
| Biofrontera Inc. | 5 | $167 |
| Organon | 11 | $147 |
| Genentech USA, Inc. | 6 | $128 |
| Regeneron | 1 | $91 |
| LEO Pharma Inc. | 4 | $84 |
| Journey Medical Corporation | 3 | $61 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $44 |
| Janssen Scientific Affairs, LLC | 1 | $36 |
| Almirall LLC | 2 | $31 |
| Merz North America, Inc. | 1 | $29 |
| Merck | 1 | $21 |
| VYNE Pharmaceuticals Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $16 |
| Strata Skin Sciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,552 in reported general payments places this provider in the 80th percentile of 203 dermatology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 43 | $534 |
| Doxycycline Hyclate | 28 | $305 |
| Ketoconazole | 15 | $262 |
| Mupirocin | 29 | $258 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Fort Mill
- Rebecca SmithFort Mill$2.3M
- Julie IanniniFort Mill$15K
- Todd SchlesingerCharleston$6.4M
- Matthew MillerGreenville$2.8M
- Marshall ShulerGreenville$2.6M
- Amylynne FrankelSpartanburg$1.3M
- Theresa KnoeppAnderson$977K
- Jessica BurgyColumbia$519K
- Richard SturtzAnderson$369K
- John KormanGreer$210K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.